Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
Journal Article
Overview
publication date
- August 1, 2009
has subject area
- Adult
- Antineoplastic Agents, Hormonal
- Breast Diseases - Breast Neoplasms
- Combined Modality Therapy - Chemotherapy, Adjuvant
- Drug Therapy - Chemotherapy, Adjuvant
- Environment and Public Health - Cohort Studies
- Environment and Public Health - Randomized Controlled Trials as Topic
- Female
- Health Care Evaluation Mechanisms - Cohort Studies
- Health Care Evaluation Mechanisms - Randomized Controlled Trials as Topic
- Health Care Evaluation Mechanisms - Treatment Outcome
- Health Services Administration - Treatment Outcome
- Humans
- Investigative Techniques - Cohort Studies
- Investigative Techniques - Randomized Controlled Trials as Topic
- Lymphatic System - Lymph Nodes
- Middle Aged
- Neoplasm Staging
- Neoplasms - Lymphatic Metastasis
- Neoplasms - Neoplasm Invasiveness
- Neoplasms - Neoplasm Recurrence, Local
- Neoplasms by Site - Breast Neoplasms
- Pathologic Processes - Lymphatic Metastasis
- Pathologic Processes - Neoplasm Invasiveness
- Pathologic Processes - Neoplasm Recurrence, Local
- Prognosis - Treatment Outcome
- Receptors, Cytoplasmic and Nuclear - Receptors, Estrogen
- Tamoxifen
- Tissues - Lymph Nodes
- Transcription Factors - Receptors, Estrogen
has restriction
- green
Date in CU Experts
- March 7, 2014 1:50 AM
Full Author List
- Dignam JJ; Dukic V; Anderson SJ; Mamounas EP; Wickerham DL; Wolmark N
author count
- 6
citation count
- 95
published in
Other Profiles
International Standard Serial Number (ISSN)
- 0167-6806
Electronic International Standard Serial Number (EISSN)
- 1573-7217
Digital Object Identifier (DOI)
Additional Document Info
start page
- 595
end page
- 602
volume
- 116
issue
- 3